Lomefloxacin·HCl is a potent fluoroquinolone antibiotic known for its broad-spectrum antibacterial activity. This compound is particularly effective against a variety of Gram-negative and Gram-positive bacteria, making it a valuable asset in both clinical and research settings. Its unique structure, featuring a piperazine moiety, enhances its ability to penetrate bacterial cells, thereby increasing its efficacy. Lomefloxacin·HCl is commonly utilized in the treatment of urinary tract infections, respiratory infections, and skin infections, providing healthcare professionals with a reliable option for combating resistant bacterial strains.

In addition to its therapeutic applications, Lomefloxacin·HCl has shown promise in various research domains, including microbiology and pharmacology. Its ability to inhibit bacterial DNA gyrase and topoisomerase IV positions it as a critical tool for studying bacterial resistance mechanisms. Researchers appreciate its favorable pharmacokinetic properties, which allow for convenient dosing regimens. With its established safety profile and effectiveness, Lomefloxacin·HCl continues to be a preferred choice for both medical and scientific applications.